View in EDS PDF Full Text

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.

Saved in:
Bibliographic Details
Title: XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.
Authors: Cassidy, J.1, Clarke, S.2, D&a#x00ED;az-Rubio, E.3, Scheithauer, W.4, Figer, A.5, Wong, R.6, Koski, S.7, Rittweger, K.8, Gilberg, F.9, Saltz, L.10, Díaz-Rubio, E (AUTHOR)
Source: British Journal of Cancer. 6/20/2011, Vol. 105 Issue 1, p58-64. 7p. 1 Diagram, 4 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/bjc.2011.201